SG11202113057XA - Ppr protein causing less aggregation and use of the same - Google Patents
Ppr protein causing less aggregation and use of the sameInfo
- Publication number
- SG11202113057XA SG11202113057XA SG11202113057XA SG11202113057XA SG11202113057XA SG 11202113057X A SG11202113057X A SG 11202113057XA SG 11202113057X A SG11202113057X A SG 11202113057XA SG 11202113057X A SG11202113057X A SG 11202113057XA SG 11202113057X A SG11202113057X A SG 11202113057XA
- Authority
- SG
- Singapore
- Prior art keywords
- same
- causing less
- less aggregation
- ppr protein
- protein causing
- Prior art date
Links
- 230000002776 aggregation Effects 0.000 title 1
- 238000004220 aggregation Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Environmental Sciences (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019100553 | 2019-05-29 | ||
| PCT/JP2020/021473 WO2020241877A1 (ja) | 2019-05-29 | 2020-05-29 | 凝集の少ないｐｐｒタンパク質及びその利用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202113057XA true SG11202113057XA (en) | 2021-12-30 |
Family
ID=73552159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202113057XA SG11202113057XA (en) | 2019-05-29 | 2020-05-29 | Ppr protein causing less aggregation and use of the same |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12559528B2 (https=) |
| EP (1) | EP3977849A4 (https=) |
| JP (4) | JP7308468B2 (https=) |
| KR (1) | KR102898966B1 (https=) |
| CN (1) | CN113966340A (https=) |
| AU (2) | AU2020283367B2 (https=) |
| CA (1) | CA3142303A1 (https=) |
| IL (2) | IL288417B2 (https=) |
| SG (1) | SG11202113057XA (https=) |
| WO (1) | WO2020241877A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7125727B1 (ja) | 2021-09-07 | 2022-08-25 | 国立大学法人千葉大学 | 核酸配列改変用組成物および核酸配列の標的部位を改変する方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006188507A (ja) * | 2004-12-10 | 2006-07-20 | Tokyo Univ Of Agriculture & Technology | 蛋白質の溶解度向上方法 |
| WO2013058404A1 (ja) | 2011-10-21 | 2013-04-25 | 国立大学法人九州大学 | Pprモチーフを利用したrna結合性蛋白質の設計方法及びその利用 |
| KR102893770B1 (ko) * | 2013-04-22 | 2025-11-28 | 고쿠리쓰다이가쿠호진 규슈다이가쿠 | 피피알 단백질을 이용하는 dna 결합성 단백질 및 그의 이용 |
| WO2017209122A1 (ja) | 2016-06-03 | 2017-12-07 | 国立大学法人九州大学 | 標的ｍＲＮＡからのタンパク質発現量を向上させるための融合タンパク質 |
| JPWO2018030488A1 (ja) | 2016-08-10 | 2019-06-13 | 富士フイルム和光純薬株式会社 | Ｐｐｒモチーフを利用したｄｎａ結合性タンパク質およびその利用 |
| JP6918686B2 (ja) | 2017-11-28 | 2021-08-11 | 東芝ライフスタイル株式会社 | 冷蔵庫 |
| KR102568600B1 (ko) | 2018-02-19 | 2023-08-23 | 삼성디스플레이 주식회사 | 표시 장치, 이를 포함하는 적층 기판, 및 표시 장치 제조방법 |
| CN114729017A (zh) * | 2019-05-29 | 2022-07-08 | 日商基因编辑力股份有限公司 | Ppr蛋白的有效制作方法及其应用 |
-
2020
- 2020-05-29 EP EP20812826.4A patent/EP3977849A4/en active Pending
- 2020-05-29 CA CA3142303A patent/CA3142303A1/en active Pending
- 2020-05-29 AU AU2020283367A patent/AU2020283367B2/en active Active
- 2020-05-29 IL IL288417A patent/IL288417B2/en unknown
- 2020-05-29 SG SG11202113057XA patent/SG11202113057XA/en unknown
- 2020-05-29 WO PCT/JP2020/021473 patent/WO2020241877A1/ja not_active Ceased
- 2020-05-29 US US17/614,236 patent/US12559528B2/en active Active
- 2020-05-29 CN CN202080040065.2A patent/CN113966340A/zh active Pending
- 2020-05-29 KR KR1020217040376A patent/KR102898966B1/ko active Active
- 2020-05-29 IL IL312349A patent/IL312349B2/en unknown
- 2020-05-29 JP JP2021521908A patent/JP7308468B2/ja active Active
-
2022
- 2022-12-26 JP JP2022208226A patent/JP7526399B2/ja active Active
-
2024
- 2024-07-08 JP JP2024109757A patent/JP7749763B2/ja active Active
-
2025
- 2025-07-07 AU AU2025205185A patent/AU2025205185A1/en active Pending
- 2025-09-24 JP JP2025158040A patent/JP2025181985A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3977849A1 (en) | 2022-04-06 |
| JP7749763B2 (ja) | 2025-10-06 |
| CN113966340A (zh) | 2022-01-21 |
| IL312349B1 (en) | 2024-12-01 |
| IL288417B2 (en) | 2024-10-01 |
| CA3142303A1 (en) | 2020-12-03 |
| JP2024138381A (ja) | 2024-10-08 |
| IL312349B2 (en) | 2025-04-01 |
| IL288417B1 (en) | 2024-06-01 |
| AU2020283367B2 (en) | 2025-04-10 |
| US20220220166A1 (en) | 2022-07-14 |
| JPWO2020241877A1 (https=) | 2020-12-03 |
| BR112021023937A2 (pt) | 2022-04-19 |
| WO2020241877A1 (ja) | 2020-12-03 |
| IL312349A (en) | 2024-06-01 |
| JP7526399B2 (ja) | 2024-08-01 |
| AU2025205185A1 (en) | 2025-07-31 |
| EP3977849A4 (en) | 2023-06-28 |
| JP7308468B2 (ja) | 2023-07-14 |
| KR20220023984A (ko) | 2022-03-03 |
| IL288417A (en) | 2022-01-01 |
| AU2020283367A1 (en) | 2022-01-06 |
| US12559528B2 (en) | 2026-02-24 |
| NZ783357A (en) | 2025-06-27 |
| JP2023036848A (ja) | 2023-03-14 |
| KR102898966B1 (ko) | 2025-12-10 |
| JP2025181985A (ja) | 2025-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202006066B (en) | Anti-hla-g antibodies and use thereof | |
| ZA202101250B (en) | Novel crispr-associated protein and use thereof | |
| SI3235830T1 (sl) | Proteinski kompleks interlevkina 15 in njegove uporabe | |
| ZA202103259B (en) | Modified cas9 protein, and use thereof | |
| IL282707A (en) | Anti-tim-3 antibodies and their use | |
| EP3802613A4 (en) | DIMER AND ITS USE | |
| IL282708A (en) | Anti-tim-3 antibodies and their use | |
| EP3831945A4 (en) | PROTEIN HETERODIMER AND ITS USE | |
| GB2600592B (en) | Polypeptide and use thereof | |
| SG11202104912SA (en) | Fusion protein and use thereof | |
| SG11202111462VA (en) | Asx-specific protein ligases and uses thereof | |
| ZA202100092B (en) | Modified cas9 protein and use thereof | |
| PL3757295T3 (pl) | Pojemnik i jego zastosowanie | |
| EP3882263A4 (en) | GLUCAGON DERIVED PEPTIDE AND USE THEREOF | |
| IL277007A (en) | Therapeutic ANTI-SPLA2-GIB antibodies and their uses | |
| GB201819200D0 (en) | Polypeptide and uses thereof | |
| IL292599A (en) | tmem219 antibodies and medical uses thereof | |
| IL290643A (en) | Peptides for transport and methods of using them | |
| IL288417A (en) | ppr protein which causes less aggregation and use | |
| IL288828A (en) | Binding factors - cd38 and their use | |
| GB2574747B (en) | Use of lambda interferons in the treatment of obesity-related disorders and related diseases | |
| EP3947418C0 (en) | PEPTIDES AND THEIR USE | |
| EP3696187A4 (en) | SYNTHETIC PEPTIDE SP4 AND ITS USE | |
| IL288426A (en) | An effective method for preparing ppr protein and using it | |
| EP3648789C0 (en) | MTMR2-S POLYPEPTIDE FOR USE IN THE TREATMENT OF MYOPATHY |